In the competitive pharma industry, commercial pressures are forcing manufacturers to increase their output of new drugs in order to maintain their market share. However, bringing new drugs to market is an expensive and risky process, encouraging more and more manufacturers to look for ways to reduce
the costs related to clinical trials. Over the past few years, outsourcing aspects of clinical trials or the entire process has proved to be an attractive alternative to keeping the process in-house.

However, outsourcing also has its risks and issues that need to be debated and discussed. Cooperation and communication with CROs, defining competencies, commitment to budget, timelines and goals as well as legal and regulatory challenges in the outsourcing countries are all issues that need to be discussed.

ViB Events’ conference on Outsourcing Clinical Trials aims to bring together the experts from both pharma and biotech companies to discuss the latest developments, introduce best practices in the area and, where possible, provide strategies for making the most of the partnerships with CROs, to ensure effectiveness and efficiency of the outsourced processes.

Through a series of presentations and interactive roundtable discussions, the unique format of the event will encourage discussion between delegates and key industry leaders in the field of clinical outsourcing.

To stay on track with latest developments and to network with other professionals in the field of clinical outsourcing, this is a conference you cannot afford to miss.